Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Transcriptional states do not always predict vascular function and pathology

Targeting the Notch ligand DLL4 in adult liver vessels induced transcriptional states associated with endothelial cell (EC) proliferation and sprouting. However, genetic and pharmacological inhibition of these angiogenic cell states did not prevent an abnormal vasculature and pathology in the liver, suggesting that transcriptional states do not always inform on the vascular phenotype and related pathophysiology.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: scRNA-seq analysis reveals changes in EC transcriptional states.

References

  1. Siebel, C. & Lendahl, U. Notch signaling in development, tissue homeostasis, and disease. Physiol. Rev. 97, 1235–1294 (2017). This review presents an overview of NOTCH signaling mechanisms, and their relevance in tissue homeostasis and disease.

    Article  CAS  PubMed  Google Scholar 

  2. Fernandez-Chacon, M., Garcia-Gonzalez, I., Muhleder, S. & Benedito, R. Role of Notch in endothelial biology. Angiogenesis 24, 237–250 (2021). This review summarizes the most important findings on the role of NOTCH in endothelial biology.

    Article  PubMed  Google Scholar 

  3. Noguera-Troise, I. et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444, 1032–1037 (2006). One of the first papers reporting that anti-DLL4 inhibits tumor growth, including of tumors resistant to anti-VEGF.

    Article  CAS  PubMed  Google Scholar 

  4. Yan, M. et al. Chronic DLL4 blockade induces vascular neoplasms. Nature 463, E6–7 (2010). This paper reported that anti-DLL4 causes vascular neoplasms, raising safety concerns about its use in the clinic.

    Article  CAS  PubMed  Google Scholar 

  5. Couch, J. A. et al. Balancing efficacy and safety of an anti-dll4 antibody through pharmacokinetic modulation. Clin. Cancer Res. 22, 1469–1479 (2016). This papers shows how anti-DLL4 related vascular toxicity can be decreased by modulating anti-DLL4 pharmacokinetics.

    Article  CAS  PubMed  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Fernández-Chacón, M. et al. Incongruence between transcriptional and vascular pathophysiological cell states. Nat. Cardiovas. Res. https://doi.org/10.1038/s44161-023-00272-4 (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Transcriptional states do not always predict vascular function and pathology. Nat Cardiovasc Res 2, 498–499 (2023). https://doi.org/10.1038/s44161-023-00279-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-023-00279-x

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing